ZA984040B - Benzenesulfonamide compounds - Google Patents

Benzenesulfonamide compounds

Info

Publication number
ZA984040B
ZA984040B ZA984040A ZA984040A ZA984040B ZA 984040 B ZA984040 B ZA 984040B ZA 984040 A ZA984040 A ZA 984040A ZA 984040 A ZA984040 A ZA 984040A ZA 984040 B ZA984040 B ZA 984040B
Authority
ZA
South Africa
Prior art keywords
alkyl
receptor
vinylene
trifluoromethyl
chem
Prior art date
Application number
ZA984040A
Other languages
English (en)
Inventor
Shuichi Ohuchida
Yuuki Nagao
Takayuki Maruyama
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of ZA984040B publication Critical patent/ZA984040B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA984040A 1997-05-15 1998-05-13 Benzenesulfonamide compounds ZA984040B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14095997 1997-05-15

Publications (1)

Publication Number Publication Date
ZA984040B true ZA984040B (en) 1998-11-20

Family

ID=15280803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984040A ZA984040B (en) 1997-05-15 1998-05-13 Benzenesulfonamide compounds

Country Status (14)

Country Link
US (1) US6235777B1 (da)
EP (1) EP0878465B1 (da)
KR (1) KR19980087031A (da)
CN (1) CN1201786A (da)
AT (1) ATE245141T1 (da)
AU (1) AU6600898A (da)
CA (1) CA2237709A1 (da)
DE (1) DE69816367T2 (da)
DK (1) DK0878465T3 (da)
ES (1) ES2203892T3 (da)
HU (1) HUP9801089A3 (da)
NO (1) NO982205L (da)
PT (1) PT878465E (da)
ZA (1) ZA984040B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001008674A1 (en) * 1999-07-29 2001-02-08 Ono Pharmaceutical Co., Ltd. Sulfonamide derivatives and remedies for allodynia
GB9930082D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
JP4175113B2 (ja) 2001-03-14 2008-11-05 小野薬品工業株式会社 Ep1アンタゴニストを有効成分として含有するうつ病の治療剤
AU2002354056A1 (en) * 2001-11-19 2003-06-10 Ono Pharmaceutical Co., Ltd. Remedies for urinary frequency
GB0317500D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Treatment of bph
RU2407736C2 (ru) * 2004-10-12 2010-12-27 Декод Дженетикс Ехф Пери-замещенные арилсульфонамидные бициклические соединения, предназначенные для лечения окклюзионного заболевания артерий
CN101076531A (zh) * 2004-10-12 2007-11-21 解码遗传学公司 用于阻塞性血管疾病的羧酸迫位取代的双环化合物
DE602005026553D1 (de) * 2004-10-12 2011-04-07 Decode Genetics Ehf Peri-substituierte bicyclische sulfonamide gegen arterielle verschlusskrankheit
CA2652152A1 (en) * 2006-05-16 2007-11-29 Decode Genetics Ehf Process for preparing 7-(acryloyl)indoles
TW200817319A (en) * 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
BRPI0807942A2 (pt) 2007-02-16 2014-07-01 Ono Pharmaceutical Co Agente terapêutico para distúrbio de excreção urinária
CN107802623B (zh) 2012-07-19 2020-10-30 开曼化学股份有限公司 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物
WO2014144610A1 (en) 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
JP2016527006A (ja) 2013-07-19 2016-09-08 ケイマン ケミカル カンパニー, インコーポレーテッド 骨成長を促進するための方法、システム、及び組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1278577C (en) 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
JP2565746B2 (ja) * 1987-10-23 1996-12-18 小野薬品工業株式会社 新規な炭素環系スルホンアミド誘導体
EP0312906A3 (en) * 1987-10-23 1990-09-05 Ono Pharmaceutical Co., Ltd. Novel sulfonamide derivatives
CA2113787A1 (en) 1993-01-29 1994-07-30 Nobuyuki Hamanaka Carbocyclic sulfonamides

Also Published As

Publication number Publication date
PT878465E (pt) 2003-12-31
CA2237709A1 (en) 1998-11-15
HUP9801089A2 (hu) 1999-11-29
HU9801089D0 (en) 1998-07-28
NO982205D0 (no) 1998-05-14
AU6600898A (en) 1998-11-19
DE69816367T2 (de) 2004-04-15
ES2203892T3 (es) 2004-04-16
DK0878465T3 (da) 2003-11-03
ATE245141T1 (de) 2003-08-15
EP0878465A3 (en) 2001-03-14
HUP9801089A3 (en) 2001-08-28
NO982205L (no) 1998-11-16
EP0878465B1 (en) 2003-07-16
DE69816367D1 (de) 2003-08-21
EP0878465A2 (en) 1998-11-18
KR19980087031A (ko) 1998-12-05
CN1201786A (zh) 1998-12-16
US6235777B1 (en) 2001-05-22

Similar Documents

Publication Publication Date Title
HU9801089D0 (en) Benzenesulfonamide compounds
ZA986801B (en) Chemical compound.
IT1256259B (it) Composti mettallocenici aventi leganti di tipo fluorenilico
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
MY129188A (en) Metalloproteinase inhibitors
GB2326418A (en) Siloxane liquid crystal materials and devices
CA2221110A1 (en) Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
IL132690A0 (en) Prostaglandin pharmaceutical compositions
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI953710A0 (fi) Uusia pyrrolokarbatsoleja
ATE408598T1 (de) Bicyclische verbindung
CA2393175A1 (en) Bridged metallocene compounds as olefin-polymerization catalysts
HU9904634D0 (en) New thiaazolidine-derivatives
NO995590D0 (no) 20-Aryl-5<alfa>-pregnan-derivater
ATE50773T1 (de) Alkylresorcinolphosphite.
ATE59372T1 (de) Fluessigkristallverbindung vom tolan-typ.
NO983133L (no) Flytforbedrende middel for mineraloljer
BR0002516A (pt) Compostos úteis em terapia
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
EP0849246A3 (en) Derivatives of 4-vinyl-4'-alpha-hydroxyethyl-biphenyl
GB9912417D0 (en) Compounds useful in therapy
CA2137623A1 (en) Phenyl-substituted 1,4-dihydropyridines
EP1580320A3 (en) Compositions for porous materials
EP0355846A3 (en) Antihypercholesterolemic nitrile compounds
MX9601953A (es) Nuevo compesto derivados de 5h-tiazolo [3,2-a] pirimidin-5-ona.